PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Eric Pauwels sold 787 shares of PTC Therapeutics stock in a transaction dated Wednesday, April 17th. The stock was sold at an average price of $25.14, for a total value of $19,785.18. Following the transaction, the chief executive officer now owns 67,694 shares in the company, […]